2018
Assessing the effects of the percentage of chronic disease in households on health payment-induced poverty in Shaanxi Province, China
Lan X, Zhou Z, Si Y, Shen C, Fan X, Chen G, Zhao D, Chen X. Assessing the effects of the percentage of chronic disease in households on health payment-induced poverty in Shaanxi Province, China. BMC Health Services Research 2018, 18: 871. PMID: 30458772, PMCID: PMC6245518, DOI: 10.1186/s12913-018-3698-1.Peer-Reviewed Original ResearchConceptsHealth payment-induced povertyNational Health Services SurveyChronic patientsChronic diseasesChina National Health Services SurveyMore chronic diseasesNational Health SurveyHealth Services SurveyHeavy economic burdenLogistic regression modelsHealth paymentsHealth SurveyMethodsThe dataEconomic burdenPatientsFurther healthcare reformProtective factorsDiseaseIncidenceServices SurveyRural areasVulnerable groupsRegression modelsHealthcare reformHousehold members
2011
Recent trends in chronic disease, impairment and disability among older adults in the United States
Hung WW, Ross JS, Boockvar KS, Siu AL. Recent trends in chronic disease, impairment and disability among older adults in the United States. BMC Geriatrics 2011, 11: 47. PMID: 21851629, PMCID: PMC3170191, DOI: 10.1186/1471-2318-11-47.Peer-Reviewed Original ResearchConceptsPrevalence of impairmentChronic diseasesOlder adultsDaily livingChronic lung diseaseMore chronic diseasesImpairment of cognitionPrevalence of disabilityOlder U.S. adultsProportion of respondentsIADL disabilityUrinary incontinenceLung diseaseHeart diseasePrevalence trendsInstrumental activitiesU.S. adultsDiseasePrevalenceImpairmentAdultsDisabilityMore diseasesRetirement StudyUnited States
2010
Geriatric Impairments and Disability: The Cardiovascular Health Study
Chaudhry SI, McAvay G, Ning Y, Allore HG, Newman AB, Gill TM. Geriatric Impairments and Disability: The Cardiovascular Health Study. Journal Of The American Geriatrics Society 2010, 58: 1686-1692. PMID: 20863328, PMCID: PMC2946108, DOI: 10.1111/j.1532-5415.2010.03022.x.Peer-Reviewed Original ResearchConceptsCardiovascular Health StudyGeriatric impairmentsHazard ratioADL disabilityChronic diseasesMobility disabilityHealth StudyMore geriatric impairmentsSubsequent ADL disabilitySubsequent functional disabilityMore chronic diseasesBody mass indexOnset of disabilityTime-dependent predictorsSingle multivariable modelFunctional disabilityMass indexNumber of impairmentsMultivariable modelDaily livingPerson examinationMore impairmentElderly personsDiseaseImpairment
1988
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
Hafler DA, Ritz J, Schlossman SF, Weiner HL. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. The Journal Of Immunology 1988, 141: 131-8. PMID: 2454256, DOI: 10.4049/jimmunol.141.1.131.Peer-Reviewed Original ResearchConceptsHuman anti-mouse antibodiesAnti-mouse responseAnti-mouse antibodiesHuman anti-mouse responseMultiple sclerosisChronic progressive multiple sclerosisPhase I clinical studyAnti-CD2 monoclonal antibodiesProgressive multiple sclerosisMore chronic diseasesT cell subpopulationsHuman immune responseT cell activationAcute immunosuppressionMAb infusionsT cell surfaceAnti-CD4Daily infusionsImmunologic responseImmunosuppressive effectsChronic diseasesIgG isotypeClinical studiesImmune responseLike antibodiesImmunosuppression with monoclonal antibodies in multiple sclerosis.
Hafler DA, Weiner HL. Immunosuppression with monoclonal antibodies in multiple sclerosis. Neurology 1988, 38: 42-7. PMID: 3260356.Peer-Reviewed Original ResearchConceptsHuman anti-mouse antibodiesChronic progressive multiple sclerosisAnti-T cell mAbsAnti-mouse antibodiesProgressive multiple sclerosisMAb infusionsMultiple sclerosisChronic diseasesT11 mAbPhase I clinical studyAnti-idiotypic activityMonoclonal antibody infusionMore chronic diseasesT cell subpopulationsAnti-mouse responseHuman immune responseAnti-idiotypic antibodiesHuman anti-mouse responseT cell activationAcute immunosuppressionT cell surfaceAntibody infusionImmunologic responseRepeated administrationIgG isotype
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply